Vir Biotechnology, Inc. (VIR) Revenue Growth
Vir Biotechnology, Inc. (VIR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | 9357.81% |
| 2021-12-31 | 1516.58% |
| 2022-12-31 | 48.64% |
| 2023-12-31 | -94.67% |
| 2024-12-31 | -13.90% |
| 2025-12-31 | -7.61% |
How VIR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| LLY | Eli Lilly and Company | 44.70% |
| MNKD | MannKind Corporation | 22.23% |
| NBIX | Neurocrine Biosciences Inc. | 21.45% |
| ARVN | Arvinas Inc. | -0.30% |
| EBS | Emergent BioSolutions Inc. | -28.81% |
These are five companies in the same sector as VIR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vir Biotechnology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("VIR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VIR | $11.50 | -1.12% | 3.02M |
| 3 | ||||
| 4 | ||||
| 5 |